Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Addus HomeCare Corporation (ADUS)
:ADUS
Holding ADUS?
Track your performance easily
ADUS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$85.94 - $136.12
Previous CloseN/A
Volume20.85K
Average Volume (3M)150.08K
Market Cap
$2.42B
Enterprise Value$2.26B
Total Cash (Recent Filing)$8.01M
Total Debt (Recent Filing)$22.48M
Price to Earnings (P/E)30.6
Beta0.70
Next Earnings
Mar 03, 2025EPS Estimate
1.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.37
Shares Outstanding18,133,116
10 Day Avg. Volume119,927
30 Day Avg. Volume150,077
Standard Deviation0.09
R-Squared0.32
Alpha-0.00289
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.13
Price to Cash Flow (P/CF)12.50
P/FCF Ratio12.90
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue1.99
Enterprise Value/Gross Profit6.64
Enterprise Value/Ebitda18.53
Forecast
1Y Price Target
$133.67Price Target Upside-0.15% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Addus Homecare News
PremiumCompany Announcements
Addus Homecare Expands with Gentiva Acquisition
PremiumCompany Announcements
Addus HomeCare Reports Strong Q3 2024 Performance
PremiumCompany Announcements
Addus HomeCare Sees Strong Q3 Growth and Expansion
PremiumPre-Earnings
Is ADUS a Buy, Before Earnings?Bulls Say, Bears Say
Bulls Say
Management And ExecutionAnalyst recommends Addus HomeCare with a market outperform rating due to its consistent execution and management's steady approach.
Revenue Growth PotentialThe Gentiva deal closed, expected to add 25% to annual revenues and 20% to EBITDA.
Strategic ExpansionThe acquisition of Gentiva's personal care operations is expected to drive significant growth, allowing ADUS to enter Texas with critical mass and expand in six other states.
Bears Say
Acquisition CostsThe implied EBITDA multiple for the acquisition is slightly higher than historical targets, indicating potential cost concerns.
Financial PerformanceGeneral and administrative expenses are anticipated to be pressured as the New York State financials will no longer be included in financial results.
Share DilutionAn additional 1.725 million shares from a public offering were included in the model.
---
Ownership Overview
1.75% Insiders
31.66% Mutual Funds
1.21% Other Institutional Investors
42.23% Public Companies and Individual Investors
ADUS FAQ
What was Addus HomeCare Corporation’s price range in the past 12 months?
Addus HomeCare Corporation lowest stock price was $85.94 and its highest was $136.12 in the past 12 months.
What is Addus HomeCare Corporation’s market cap?
Addus HomeCare Corporation’s market cap is $2.42B.
When is Addus HomeCare Corporation’s upcoming earnings report date?
Addus HomeCare Corporation’s upcoming earnings report date is Mar 03, 2025 which is in 44 days.
How were Addus HomeCare Corporation’s earnings last quarter?
Addus HomeCare Corporation released its earnings results on Nov 04, 2024. The company reported $1.3 earnings per share for the quarter, beating the consensus estimate of $1.283 by $0.017.
Is Addus HomeCare Corporation overvalued?
According to Wall Street analysts Addus HomeCare Corporation’s price is currently Overvalued.
Does Addus HomeCare Corporation pay dividends?
Addus HomeCare Corporation does not currently pay dividends.
What is Addus HomeCare Corporation’s EPS estimate?
Addus HomeCare Corporation’s EPS estimate is 1.36.
How many shares outstanding does Addus HomeCare Corporation have?
Addus HomeCare Corporation has 18,133,116 shares outstanding.
What happened to Addus HomeCare Corporation’s price movement after its last earnings report?
Addus HomeCare Corporation reported an EPS of $1.3 in its last earnings report, beating expectations of $1.283. Following the earnings report the stock price went down -3.714%.
Which hedge fund is a major shareholder of Addus HomeCare Corporation?
Among the largest hedge funds holding Addus HomeCare Corporation’s share is Woodline Partners LP. It holds Addus HomeCare Corporation’s shares valued at 11M.
---
Addus Homecare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$133.67 (-0.15% Downside)
$133.67 (-0.15% Downside)
Blogger Sentiment
Bullish
ADUS Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 55.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $272.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
49.24%
12-Months-Change
Fundamentals
Return on Equity
9.03%
Trailing 12-Months
Asset Growth
11.31%
Trailing 12-Months
Company Description
Addus HomeCare Corporation
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.
---
ADUS Company Deck
---
ADUS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with strong revenue and earnings growth, significant cash reserves, and strategic acquisitions positioning the company for future expansion. However, challenges remain in the Home Health segment and with CMS reimbursement pressures. Overall, the highlights outweigh the lowlights, indicating a positive sentiment.Read More>---
ADUS Stock 12 Month Forecast
Average Price Target
$133.67
▼(-0.15% Downside)
Technical Analysis
Amedisys
―
Encompass Health
―
Chemed
―
Brookdale Senior Living
―
Select Medical
―
Nevro Corp
―
Best Analysts Covering ADUS
1 Year
1 Year Success Rate
12/14 ratings generated profit
1 Year Average Return
+22.04%
assigned a buy rating last month
Copying Joanna Gajuk's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +22.04% per trade.
---